Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

INSM Insmed

交易中 12-22 10:03:40 EST

178.26

+3.42

+1.96%

最高179.33	最低174.00	成交量34.13万
今开178.95	昨收174.84	日振幅3.05%
总市值376.80亿	流通市值345.82亿	总股本2.11亿
成交额6,037万	换手率0.18%	流通股本1.94亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"INSM","market":"US","secType":"STK","nameCN":"Insmed","latestPrice":178.26,"timestamp":1766415819953,"preClose":174.84,"halted":0,"volume":341311,"delay":0,"floatShares":194000000,"shares":211374786,"eps":-6.219318,"marketStatus":"交易中","change":3.42,"latestTime":"12-22 10:03:40 EST","open":178.95,"high":179.325,"low":174,"amount":60366799.40073001,"amplitude":0.030456,"askPrice":178.32,"askSize":7,"bidPrice":177.87,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-6.219318,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766437200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":959832000000,"exchange":"NASDAQ","adjPreClose":174.84,"preHourTrading":{"tag":"盘前","latestPrice":178,"preClose":174.84,"latestTime":"09:27 EST","volume":2900,"amount":512272.64599999995,"timestamp":1766413630078},"postHourTrading":{"tag":"盘后","latestPrice":174.84,"preClose":174.84,"latestTime":"19:39 EST","volume":3072357,"amount":537168849.706499,"timestamp":1766191147167},"volumeRatio":0.436454,"impliedVol":0.5253,"impliedVolPercentile":0.508},"requestUrl":"/m/hq/s/INSM","defaultTab":"news","newsList":[{"id":"1159401717","title":"Insmed股票在盘前交易中下跌20.1%，因公司中期研究失败后停止鼻窦药物开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1159401717","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159401717?lang=zh_cn&edition=full","pubTime":"2025-12-18 18:30","pubTimestamp":1766053814,"startTime":"0","endTime":"0","summary":"Insmed股票在盘前交易中下跌20.1%，因公司中期研究失败后停止鼻窦药物开发。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"f9f3169eeaffd188a4d97d9b846e92ea","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU0320765992.SGD","INSM","LU0109394709.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"1188873548","title":"美股夜盘 | 美光科技绩后涨超8%，大麻股CGC涨超13%；INSM暴跌18%，CART跌近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1188873548","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188873548?lang=zh_cn&edition=full","pubTime":"2025-12-18 09:05","pubTimestamp":1766019931,"startTime":"0","endTime":"0","summary":"12月18日，美股夜盘时段，$美光科技(MU)$涨超8%，芯片需求旺盛，业绩与指引双双“爆表”；受此消息影响，存储概念股集体走高，$SanDisk Corp(SNDK)$涨超5%，$西部数据(WDC)$涨超2%。大麻股夜盘上涨，$Canopy Growth(CGC)$涨超13%，Tilray涨超5%。报道称特朗普拟于周四签署行政令重新归类大麻；医疗用品供应商Medline夜盘跌超2%，其上市首日股价涨超40%；","market":"us","thumbnail":"https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d8fb95e65f042f352c6313989391357"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","BK4543","BK4512","BK4553","BK4527","BK4141","INSM","BK4575","BK4588","BK4532","CART","BK4585","BK4554","BK4605","BK4533","BK4579","MDLN","MU","TLRY"],"gpt_icon":0},{"id":"1173952258","title":"Insmed收购二期临床准备的单克隆抗体 以应对潜在的呼吸系统及免疫与炎症相关指示","url":"https://stock-news.laohu8.com/highlight/detail?id=1173952258","media":"美股速递","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1173952258?lang=zh_cn&edition=full","pubTime":"2025-12-18 05:03","pubTimestamp":1766005391,"startTime":"0","endTime":"0","summary":"Insmed收购二期临床准备的单克隆抗体 以应对潜在的呼吸系统及免疫与炎症相关指示","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU0053671581.USD","LU0109394709.USD","LU0889565916.HKD","BK4139","INSM"],"gpt_icon":0},{"id":"1168222595","title":"Insmed Inc - Brensocatib在CRSSNP的2B期Birch研究未达到主要或次要疗效指标","url":"https://stock-news.laohu8.com/highlight/detail?id=1168222595","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168222595?lang=zh_cn&edition=full","pubTime":"2025-12-18 05:03","pubTimestamp":1766005391,"startTime":"0","endTime":"0","summary":"Insmed Inc - Brensocatib在CRSSNP的2B期Birch研究未达到主要或次要疗效指标","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","INSM","LU0109394709.USD","LU0053671581.USD","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"1131212462","title":"纳斯达克公司：阿尔尼拉姆制药、Ferrovial、Insmed、单片电源系统、希捷科技、西部数据将被纳入纳斯达克100指数","url":"https://stock-news.laohu8.com/highlight/detail?id=1131212462","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1131212462?lang=zh_cn&edition=full","pubTime":"2025-12-13 09:09","pubTimestamp":1765588155,"startTime":"0","endTime":"0","summary":"纳斯达克公司：阿尔尼拉姆制药、Ferrovial、Insmed、单片电源系统、希捷科技、西部数据将被纳入纳斯达克100指数","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0edbc198404a72334f079a67157af149","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930730.SGD","LU1815336760.USD","IE00BN0W2T93.GBP","LU0314104364.USD","STX","WDC","LU0353189680.USD","BK4585","BK4139","LU0320765059.SGD","LU2272731600.USD","LU1861220033.SGD","LU0053671581.USD","IE00BGHQF748.EUR","LU1670628061.USD","SG9999014013.SGD","LU0708995401.HKD","LU2360107168.USD","IE00B894F039.SGD","LU0353189763.USD","IE00BN0W2W23.USD","LU2322448957.HKD","LU0081259029.USD","LU0882574055.USD","LU2089985449.USD","BK4170","LU0114720955.EUR","LU2087625088.SGD","LU2322448791.USD","NDAQ","BK4512","LU0889565916.HKD","LU2272731782.SGD","LU1823568750.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","LU2250418816.HKD","LU2290526834.HKD","SG9999014021.USD","INSM","BK4112","LU2272731865.HKD","IE00BD6J9T35.USD","LU0109391861.USD","SG9999014005.SGD","LU1046421795.USD","LU2360106780.USD","LU0109394709.USD","LU1670627923.USD","LU1035773651.USD","LU2473716301.USD","BK4548","LU2210149790.SGD","LU0203345920.USD","IE00B19Z9P08.USD","BK4588","LU1861215975.USD","LU0476273544.USD","LU0320765992.SGD","LU1069347547.HKD","IE00BKPKM429.USD","LU2095319765.USD","LU0056508442.USD","SG9999014039.USD","LU0672654240.SGD","IE00B19Z9Z06.USD","LU0006061336.USD","MPWR","LU0274383776.USD","IE00B64PRP62.GBP","LU0444971666.USD","BK4141","LU0444973449.USD","LU1642822529.SGD","LU1992135472.HKD","LU2931357623.SGD","LU1992135399.USD","LU1852331112.SGD","ALNY","LU0203347892.USD","IE00BN0W2V16.EUR","LU0957808578.USD","LU1235294995.USD"],"gpt_icon":0},{"id":"1197329900","title":"Insmed将于2026年初与欧盟当局互动，确保合格患者获取Brinsupri","url":"https://stock-news.laohu8.com/highlight/detail?id=1197329900","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1197329900?lang=zh_cn&edition=full","pubTime":"2025-11-19 00:03","pubTimestamp":1763481792,"startTime":"0","endTime":"0","summary":"Insmed将于2026年初与欧盟当局互动，确保合格患者获取Brinsupri","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053671581.USD","LU0320765992.SGD","INSM","LU0109394709.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"1121135608","title":"欧洲委员会批准Brinsupri™（Brensocatib）作为欧盟唯一获批的非囊性纤维化支气管扩张症治疗药物","url":"https://stock-news.laohu8.com/highlight/detail?id=1121135608","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121135608?lang=zh_cn&edition=full","pubTime":"2025-11-19 00:01","pubTimestamp":1763481679,"startTime":"0","endTime":"0","summary":"欧洲委员会批准Brinsupri™（Brensocatib）作为欧盟唯一获批的非囊性纤维化支气管扩张症治疗药物。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","BK4139","LU0053671581.USD","INSM","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2576055837","title":"EMA十月药品审评会议：赛诺菲(SNY.US)、Insmed(INSM.US)等公司新药获上市推荐","url":"https://stock-news.laohu8.com/highlight/detail?id=2576055837","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576055837?lang=zh_cn&edition=full","pubTime":"2025-10-17 21:29","pubTimestamp":1760707780,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，在本周召开的会议上，欧洲药品管理局的专家小组对赛诺菲与Insmed的两款新药做出了推荐在该地区上市的积极意见。除了推荐新药获批外，该委员会还否决了赛诺菲的一款新药，并推荐了8项新的药品适应症扩展申请。赛诺菲表示，这一决定基于该公司关键的LUNA 3期临床试验。该公司表示，CHMP的这一决定令人失望，并将寻求对该决定进行重新审查。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1356643.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SNY","BK4588","BK4139","LU0053671581.USD","EMA","INSM","BK4585","BK4081","BK4007","LU0109394709.USD","IE00BFXG1179.USD","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"1135371274","title":"CHMP建议欧盟批准Brinsupri™（Brensocatib）用于非囊性纤维化支气管扩张症的治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1135371274","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135371274?lang=zh_cn&edition=full","pubTime":"2025-10-17 19:01","pubTimestamp":1760698885,"startTime":"0","endTime":"0","summary":"CHMP建议欧盟批准Brinsupri™（Brensocatib）用于非囊性纤维化支气管扩张症的治疗","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889565916.HKD","INSM","BK4139","LU0053671581.USD","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"1165253215","title":"高盛将沃尔玛、瓦莱罗能源加入9月“确信名单”，还有这些公司入选","url":"https://stock-news.laohu8.com/highlight/detail?id=1165253215","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165253215?lang=zh_cn&edition=full","pubTime":"2025-09-03 13:45","pubTimestamp":1756878304,"startTime":"0","endTime":"0","summary":"高盛在9月的确信名单中新增了四只股票，其中既包括美国一些最知名的品牌，也有部分能源股。不过，高盛指出，移出名单并不一定意味着其对相关股票的基本投资评级发生了改变。高盛根据营收增长、当前股息收益率等多重指标，认为这些公司具有投资吸引力。截至目前，该股年内已上涨 8%。高盛对沃尔玛的“买入”评级与华尔街整体观点一致。高盛认为，其股价还有 7% 的上行空间。","market":"us","thumbnail":"https://community-static.tradeup.com/news/ebd93ab0fd3bcb1f3363cb69f435ed88","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ebd93ab0fd3bcb1f3363cb69f435ed88"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"高盛将沃尔玛、瓦莱罗能源加入9月“确信名单”，还有这些公司入选","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CDNS","MCD","WMT","VLO","VNOM","GEV","INSM"],"gpt_icon":1},{"id":"2562083099","title":"Bybit 上线 BLSH、INSM 和 TME 股票 CFD","url":"https://stock-news.laohu8.com/highlight/detail?id=2562083099","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562083099?lang=zh_cn&edition=full","pubTime":"2025-08-28 15:20","pubTimestamp":1756365602,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，Bybit 现已上线 BLSH、INSM 和 TME 股票 CFD 交易，用户可前往平台进行交易。 ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2201486","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BYQNZ168.SGD","LU0359201612.USD","LU2039709279.SGD","BK4112","IE00B12V2V27.USD","BK4139","LU0456842615.SGD","BK4563","LU0053671581.USD","BLSH","LU0320765992.SGD","LU1023057109.AUD","BK4552","TME","BK4531","BK4565","BK4548","INSM","BK4108","LU0109394709.USD","SG9999011746.SGD","01698","IE00BYTNYN87.SGD","LU0889565916.HKD","BK4509","BK4571","BK4535","BK4526","LU0359202008.SGD"],"gpt_icon":0},{"id":"1135739773","title":"异动解读 | Insmed股价盘后大涨5.77%，FDA批准其肺病新药上市","url":"https://stock-news.laohu8.com/highlight/detail?id=1135739773","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135739773?lang=zh_cn&edition=full","pubTime":"2025-08-14 05:54","pubTimestamp":1755122077,"startTime":"0","endTime":"0","summary":"周三盘后，生物制药公司Insmed股价大涨5.77%。引发投资者热情的是该公司重磅新药获得美国食品药品监督管理局批准上市的消息。FDA批准了Insmed公司的口服药物Brinsupri用于治疗非囊性纤维化支气管扩张症，这是首个获批用于该适应症的药物。这一批准被视为Insmed公司的重大突破。RBC Capital Markets分析师表示，此次批准是\"最好的情况\"，两种剂量均获批准，无重大警告。摩根大通预计，到2033年，Brinsupri的年销售额有望突破70亿美元。这些乐观预期推动了Insmed股价的强势上涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSM"],"gpt_icon":0},{"id":"1107188636","title":"异动解读 | Insmed股价盘中大涨5.25%，FDA批准其肺病新药","url":"https://stock-news.laohu8.com/highlight/detail?id=1107188636","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1107188636?lang=zh_cn&edition=full","pubTime":"2025-08-12 23:58","pubTimestamp":1755014314,"startTime":"0","endTime":"0","summary":"生物制药公司Insmed今日盘中股价大涨5.25%，引发市场广泛关注。消息面上，美国食品和药物管理局批准了Insmed公司的一款口服肺病新药Brinsupri。值得注意的是，Brinsupri是Insmed公司治疗慢性病的第一种药物。该药物的作用机制是阻断白细胞中的某些炎症酶，防止它们过度活跃并损伤肺部。这一重大突破不仅为患者带来了新的治疗选择，也标志着Insmed在开发创新疗法方面取得了重要进展，这可能是推动其股价上涨的主要原因。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["INSM"],"gpt_icon":0},{"id":"2558690987","title":"Insmed Incorporated8月11日成交额为3.73亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558690987","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558690987?lang=zh_cn&edition=full","pubTime":"2025-08-12 11:14","pubTimestamp":1754968446,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Insmed Incorporated成交额为3.73亿美元，成交额较昨日增加5.82%，当日成交量为331.26万股。Insmed Incorporated于2025年8月11日涨3.05%，报112.89美元，该股过去5个交易日涨1.48%，年初至今涨63.51%，过去60日涨72.06%。该公司还在开发Brensocatib，一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂，一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812111407a4831ea8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812111407a4831ea8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0053671581.USD","LU0889565916.HKD","INSM","LU0320765992.SGD"],"gpt_icon":0},{"id":"2558950553","title":"Insmed Incorporated8月8日成交额为3.52亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558950553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558950553?lang=zh_cn&edition=full","pubTime":"2025-08-09 11:12","pubTimestamp":1754709147,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Insmed Incorporated成交额为3.52亿美元，成交额较昨日减少3.27%，当日成交量为323.41万股。Insmed Incorporated于2025年8月8日涨0.23%，报109.55美元，该股过去5个交易日涨0.79%，年初至今涨58.68%，过去60日涨66.72%。该公司还在开发Brensocatib，一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂，一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809111233a6dbfe25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809111233a6dbfe25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0053671581.USD","LU0320765992.SGD","LU0889565916.HKD","INSM"],"gpt_icon":0},{"id":"2557519714","title":"Insmed Incorporated8月7日成交额为3.64亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557519714","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557519714?lang=zh_cn&edition=full","pubTime":"2025-08-08 11:10","pubTimestamp":1754622650,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Insmed Incorporated成交额为3.64亿美元，成交额较昨日减少8.09%，当日成交量为333.52万股。Insmed Incorporated于2025年8月7日跌1.76%，报109.3美元，该股过去5个交易日涨1.88%，年初至今涨58.31%，过去60日涨61.33%。该公司还在开发Brensocatib，一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂，一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808111057a47c3621&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808111057a47c3621&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4139","LU0053671581.USD","INSM","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2557580896","title":"Insmed Incorporated8月6日成交额为3.96亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557580896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557580896?lang=zh_cn&edition=full","pubTime":"2025-08-07 11:07","pubTimestamp":1754536042,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Insmed Incorporated成交额为3.96亿美元，成交额较昨日增加8.37%，当日成交量为356.79万股。Insmed Incorporated于2025年8月6日跌0.31%，报111.26美元，该股过去5个交易日涨5.78%，年初至今涨61.15%，过去60日涨70.96%。该公司还在开发Brensocatib，一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂，一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807110732a6d7c463&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807110732a6d7c463&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0053671581.USD","BK4139","LU0889565916.HKD","INSM","LU0109394709.USD"],"gpt_icon":0},{"id":"2557200341","title":"Insmed Incorporated8月5日成交额为3.65亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557200341","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557200341?lang=zh_cn&edition=full","pubTime":"2025-08-06 11:02","pubTimestamp":1754449378,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Insmed Incorporated成交额为3.65亿美元，成交额较昨日增加47.75%，当日成交量为326.03万股。Insmed Incorporated于2025年8月5日涨0.33%，报111.61美元，该股过去5个交易日涨6.3%，年初至今涨61.66%，过去60日涨70.06%。该公司还在开发Brensocatib，一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂，一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806110304a477be7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806110304a477be7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4139","LU0109394709.USD","LU0320765992.SGD","INSM","LU0053671581.USD"],"gpt_icon":0},{"id":"2557359647","title":"Insmed Incorporated8月4日成交额为2.47亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557359647","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557359647?lang=zh_cn&edition=full","pubTime":"2025-08-05 11:01","pubTimestamp":1754362904,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Insmed Incorporated成交额为2.47亿美元，成交额较昨日增加1.70%，当日成交量为224.90万股。Insmed Incorporated于2025年8月4日涨2.35%，报111.24美元，该股过去5个交易日涨9.33%，年初至今涨61.12%，过去60日涨62.92%。该公司还在开发Brensocatib，一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂，一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805110150a6d389e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805110150a6d389e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","LU0109394709.USD","LU0320765992.SGD","LU0053671581.USD","LU0889565916.HKD","BK4139"],"gpt_icon":0},{"id":"2556984785","title":"Insmed Incorporated8月1日成交额为2.43亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556984785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556984785?lang=zh_cn&edition=full","pubTime":"2025-08-02 11:01","pubTimestamp":1754103697,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Insmed Incorporated成交额为2.43亿美元，成交额较昨日增加1.59%，当日成交量为225.62万股。Insmed Incorporated于2025年8月1日涨1.31%，报108.69美元，该股过去5个交易日涨4.56%，年初至今涨57.43%，过去60日涨60.14%。该公司还在开发Brensocatib，一种用于支气管扩张和其他中性粒细胞介导疾病的口服可逆二肽基肽酶1抑制剂以及Treprostinil Palmitil吸入粉剂，一种用于治疗与间质性肺病和肺动脉高压相关的肺动脉高压的吸入性treprostiil前药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802110143a6cebc7b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802110143a6cebc7b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["INSM","LU0320765992.SGD","LU0889565916.HKD","BK4139","LU0053671581.USD","LU0109394709.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insmed.com","stockEarnings":[{"period":"1week","weight":-0.1125},{"period":"1month","weight":-0.1411},{"period":"3month","weight":0.2078},{"period":"6month","weight":0.7028},{"period":"1year","weight":1.5189},{"period":"ytd","weight":1.5324}],"compareEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0271},{"period":"3month","weight":0.0254},{"period":"6month","weight":0.1452},{"period":"1year","weight":0.1612},{"period":"ytd","weight":0.1613}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insmed Incorporated是一家生物制药公司，专注于研发吸入疗法为患者对抗危及生命的肺部疾病。公司主打产品ARIKACE和阿米卡星脂质体吸入剂是一种吸入的抗生疗法，证明抗感染药在治疗肺部重感染疾病时能提升该疗法的效果，安全性阿和便利性。公司于1999年11月29日在英联邦弗吉尼亚州成立。","yearOnYearQuotes":[{"month":1,"riseRate":0.470588,"avgChangeRate":0.071463},{"month":2,"riseRate":0.411765,"avgChangeRate":0.079066},{"month":3,"riseRate":0.371429,"avgChangeRate":-0.053836},{"month":4,"riseRate":0.4,"avgChangeRate":0.04767},{"month":5,"riseRate":0.4,"avgChangeRate":0.067566},{"month":6,"riseRate":0.542857,"avgChangeRate":0.027147},{"month":7,"riseRate":0.485714,"avgChangeRate":0.004271},{"month":8,"riseRate":0.4,"avgChangeRate":-0.021648},{"month":9,"riseRate":0.571429,"avgChangeRate":0.032075},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.015562},{"month":11,"riseRate":0.657143,"avgChangeRate":0.105034},{"month":12,"riseRate":0.457143,"avgChangeRate":0.040951}],"exchange":"NASDAQ","name":"Insmed","nameEN":"Insmed"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Insmed,INSM,Insmed股票,Insmed股票老虎,Insmed股票老虎国际,Insmed行情,Insmed股票行情,Insmed股价,Insmed股市,Insmed股票价格,Insmed股票交易,Insmed股票购买,Insmed股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Insmed(INSM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Insmed(INSM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}